In addition, the SBM endpoint demonstrated nearly significant and significant differences between the active and the placebo group at week 2 (p = 0.077), week 3 (p = 0.000), and week 4 (p = 0.020) (Table 2 , Figure 2 ).
← all excerpts
Effects of Kivia powder on gut health in patients with occasional constipation: a randomized, double-blind, placebo-controlled study.
1
—
—